match will be positive with virtual every red cell unit tested. Methods: In this study, we applied high-throughput blood group SNP genotyping on >37,000 Swiss blood donors, intending to identify homozygous carriers of low-frequency blood group antigens (LFA). Results: 326 such individuals were identified and made available to transfusion specialists for future support of patients in need of rare blood products. Conclusion: Thorough comparison of minor allele frequencies using population genetics revealed heterogeneity of allele distributions among Swiss blood donors which may be explained by the topographical and cultural peculiarities of Switzerland. Moreover, geographically localized donor subpopulations are described which contain above-average numbers of individuals carrying rare blood group genotypes.
Introduction
One of the challenges in transfusion medicine is to provide compatible blood for patients negative for a high-frequency blood group antigen (HFA) and who have an alloantibody against the antigen [1] . Such HFA negativity may either be caused by a complete lack of the protein serving as carrier of a certain blood group system with concomitant negativity for all its associated antigens, or by the lack of only one specific antigen, because of the presence of an identical variant blood group protein inherited on both parental haplotypes. Low-frequency blood group antigens (LFA) are the less frequent antithetic variants of HFAs. LFAs do not create a major transfusion problem from the aspect of finding compatible donors. However, a potentially dangerous antibody to an LFA could remain undetected if a full cross-match analysis was not performed [2] .
The Kell blood group system is an exemplary model for the above-mentioned model. The system is highly polymorphic and expresses 36 antigens, all encoded on a type II glycoprotein of 732 amino acids encoded by the KEL gene and its allelic variants [3, 4] . Some of the Kell antigens have been classified into antithetical pairs, each represented by one HFA and its correspondent LFA, e.g. K and k or Kp a and Kp b , others being independently expressed or having unknown antithetical partners. KEL2 or k+, formerly also named 'Cellano', is a HFA and its antithetical variant is the LFA: KEL1 or K+. As a result, K+ k-homozygous individuals are encountered only rarely, e.g. at an exemplary frequency of 1 per 1,371 Swiss [5] . While, K+ k-individuals still express other Kell antigens, e.g. Kp b or KEL11, none of the Kell antigens are expressed on cells of the Kell-null phenotype, K 0 , which arise from homozygous or compound heterozygous KEL-inactivating mutations [6] [7] [8] . K 0 individuals are exceedingly rare and may only be found at frequency fewer than 1 individual per 1 million Austrians [6] .
Some blood types are extremely scarce worldwide, and requests for transfusion are particularly difficult to fulfill. On the other side of the frequency spectrum, e.g. where prevalence of certain antigens is shifting towards 'public antigen frequency', a generally accepted numerical definition for 'rarity' is lacking. For instance, Dblood is common in Caucasians (approximately 15% of the population), but it is rare in Asia (less than 1%) [2] . In some nations, a blood type with a prevalence of 1 in 100 is considered rare, whereas in other countries, the same status requires antigen prevalence of less than 1 in 5,000. Moreover, in some programs, rare donors are exclusively determined by being negative for single HFAs, whereas in other programs, donors negative for a combination of several public (common) red cell antigens are also recognized as being rare. As a consequence, the definition of a 'rare donor' is widely different, as vividly demonstrated by the existent variety of national rare donor programs [9] .
Traditionally, red cell antigens have been identified by serology. Recent advances in molecular biology made it possible to genotype most of the blood group antigens employing high-throughput technology platforms [10] . Also, today, blood group antigens without suitable anti-sera -such as Scianna and Dombrock -are screened for using high-throughput genotyping methods [11, 12] .
The presented project was conducted for the main purpose to ensure the supply of rare blood units to the Swiss population. MALDI-TOF MS was adapted and used to genotype 37,253 Swiss blood donors by a customized 'RARE module' covering 26 blood group single nucleotide polymorphisms (SNPs) including 22 antithetical HFA/LFA pairs (table 1) [13] .
Material and Methods

Samples
Between 2012 and 2014, samples from 37,253 blood donors were collected at different sites throughout Switzerland. Donor samples were provided by 11 regional blood transfusion services (BTSs) headed in Geneva (n = 1,348), Lausanne (n = 1,526), Neuchâtel (n = 1,029), Sion (n = 760), Basel (n = 1,222), Aarau (n = 855), Luzern (n = 2,770), Zurich (n = 24,058), Lugano (n = 768), St. Gallen (n = 1,476), and Chur (n = 1,441). In 2012, blood donations were collected by 13 independent BTSs, most of them covering more than their administrativeregional area, also known as 'cantons'. As a consequence, respective inhabitant numbers and deduced 'coverage' of every BTS given need to be considered as approximate (table 2) . The ethical approval of the study was waived by the ethical committee of the Canton of Zurich, and all donors explicitly permitted genetic laboratory investigations by written consent.
Blood Group Polymorphisms, SNPs, Analyzed by MALDI-TOF MS 'RARE Module'
For automated DNA extraction, magnetic bead technology was used (Chemagen; Perkin Elmer, Baesweiler, Germany). Assay design for all SNPs (table 1) , quality control of the primer mixes, and MALDI-TOF MS-based genotyping was done as described previously [5] .
Prior to implementation of the 'RARE module' into routine use, molecular typing performance was validated by assessing a panel of 95 natural and artificial, reference DNAs representing all blood group specificities of the module. Additionally, every individual typing batch was controlled for specificity, using the identical reference DNA panel. Reference DNAs representing the blood group phenotypes, Lu(a+b-), KK, Kp(a+b-) and Yt(a-b+), and heterozygous phenotypes representative of Lu(08+14+), Au(a+b+), Js(a+b+), KEL(11+ 7+) and Do(a+b+) were provided by BTS Zurich [5, [14] [15] [16] . Sample material of individuals with phenotypes Di(a+b+), Wr(a+b+), Co(a-b+), and Kn(a-b+) was given by Susanne Kilga-Nogler (Zentralinstitut für Bluttransfusion und Immunologische Abteilung, Innsbruck, Austria). Indian, In(a+b-), reference DNAs were provided by Joyce Pool (International Blood Group Reference Laboratory, NHS Blood and Transplant, Bristol, UK). Sample material of Vel-individuals was provided by Christof Jungbauer (Austrian Red Cross, Blood Service for Vienna, Lower Austria and Burgenland, Vienna, Austria).
Artificially synthesized control DNAs were used in cases where natural blood group DNA was not available and were generated by standard PCRs using one mutated and one regular amplification primer each, in order to cover the respective polymorphic SNPs. Artificial DNA fragments were generated for the following LFAs and their antithetical HFA partners: SC2 (SC*02), LW [17] [18] [19] [20] [21] . Before use, artificial DNA fragments were titrated to equimolar copy concentrations as found in genomic DNA extracts from donor samples before validation. Absolute allele frequencies were calculated by direct allele counting (table 3) according to Hardy-Weinberg proportions for all samples originating from the greater area covered by BTS Zurich and are given as 'minor allele frequencies' (MAF) [24] . Allele frequencies of individual BTSs were calculated by direct allele counting as described above and, in order to give an averaged 'Swiss allele frequency', statistically corrected (weighted) according to the number of inhabitants of the areas covered by the respective BTSs (tables 2, 4). Additionally, for each allele, the mean, standard deviation (SD) and coefficient of correlation (CV) across all cantons is given (supplementary table 1; available at http://content.karger.com/ProdukteDB/produkte.asp?doi=490714). The coefficient of correlation is calculated by division of the SD of the mean and is a measure of dispersion that is independent of the scale. We also checked for correlation between sample size and MAF using the rank correlation coefficient by Spearman [25] .
To visualize overall similarities in relative blood group frequencies among BTSs, we performed a principal coordinate analysis (PCoA) on the relative blood frequencies using the R-package ape 5.0. Cantons with comparable blood group frequency will cluster closely together in this analysis, whereas those with unequal blood group frequency will spread apart. In population genetics, a measure of population structure is the fixation index (here F ST [26] ) that is usually calculated on SNPs or microsatellite data. F ST can take a value between 0 and 1. In simplified terms, the smaller the F ST the more similar the genetic background and vice versa. Here we use F ST to elucidate population substructures based on blood group antigens. The PCoA was performed on the minor blood group alleles having a frequency of >0.1% across all cantons, using an Eucledian distance measure, and on F ST using it as distance measure. Since we used the F ST as distance measure for the second PCoA, we calculated the variance explained by the first two PCoA components across only the positive eigenvalues. To visualize pairwise (comparison of each canton to the rest) F ST values, we plotted a heatmap using the gplots package 3.0.1 of R. In short, a heatmap plots the differences of the input values using different color intensities. Dendrograms are constructed using hierarchical clustering to depict overall similarities of features using the complete linkage algorithm [27] . We also performed pairwise Fisher's exact tests for each blood group on the contingency tables listing the absolute frequencies of the respective homozygous and heterozygous antigen counts for the analyzed cantons. We adjusted for the sample size of the different panels as described (supplementary table 2; available at http://content.karger.com/ProdukteDB/produkte.asp?doi=490714) [28] . Moreover, we adjusted for multiple testing using the correction proposed by Benjamini and Hochberg [29] .
Results
MALDI-TOF MS-Based 'RARE Module'
The 'RARE module' consisted of two multiplex reactions, comprising a total of 26 biallelic or triallelic SNP assays for the simultaneous analysis of 13 blood group genes and 40 of their alleles, rep- Top to bottom: Numbers of frequent homo-(AA), hetero-(Aa), and rare homozygotes(aa) and invalid typings for each BTS, identified by their respective head quarter locations, ordered according to geographical latitude from West to East. Left to right: antigens tested, ordered according to the ISBT number of the respective blood group system. Donors with rare blood group phenotypes are underlayed in gray (excluding blood group system Knops) and are summing up to a total of 326 (line 'rare homo' of total numbers). Only 23,886 and 23,848 blood donors, were analyzed for Scianna rs56025238 and Vel rs566629828, respectively. Donor samples not tested for these antigens are indicated as n.t. Both multiplexes included additional assays, one each for gender determination, and three additional assays for the specific detection of ABO SNPs, located at coding nucleotide positions 261, 802 and 803. The respective assays served as quality control measure, e.g. to link DNA samples to their available donor phenotype data, thereby allowing for the exclusion of serial sample mistake. Comparison of ABO geno-and serotyping will be published elsewhere (manuscript in preparation). Calling failures, caused by samples with either a negative result for all SNPs or for only a single SNP assay failure, were excluded from the finally analyzed data set and ranged between 1.40% and 3.73% per assay (average 1.87%, median 1.78%; table 3, bottom line).
Rare Blood Donors Negative for HFAs and Homozygous Positivity for LFAs
The identified individuals with rare blood group antigen constellations had genotypes, known to encode for the blood group phenotypes Lu(a+b-) (n = 42), Lu(8-14+) (n = 7), K+k-(n = 68), Kp(a+b-) (n = 7), Di(a+b-) (n = 1), Yt(a-b+) (n = 143), Co(a-b+) (n = 52), LW(a-b+) (n = 1), Vel-(n = 5), summing up to a total of n = 326 (table 3) . Knops blood group antigens are defined by clinically insignificant antibodies, but are notoriously difficult to identify [2] . Therefore, individuals with predicted phenotypes Kn(ab+) (n = 25), McC(a-b+) (n = 4), heterozygous for Vil+/-(n = 216) ,and homozygous for Vil+ (n = 16) are listed separately from the above. All donors beside those showing rare Knops phenotypes were reported to the Swiss Rare Donor File [31] . Successive samples of rare genotype carriers were used for serological confirmation of genotype. So far, the reinvestigated individuals with the following phenotypes were: Lu(a+b-) (n = 15 of 42), K+k-(n = 26 of 68), Kp(a+b-) (n = 2 of 7), Di(a+b-) (n = 1 of 1), Yt(a-b+) (n = 52 of 143), Co(a-b+) (n = 18 of 52).
Blood Group Allele Frequencies
Genotyping allowed for the identification of frequent and rare homozygous and heterozygous genotypes, the later in some cases not detectable by serologic testing. For instance, using standard serological methods, Vel positivity is undistinguishable in between VEL*01/ VEL*-01 heterozygotes and VEL*01/ VEL*01 homozygotes. On a molecular and statistical basis however, heterozygotes will be recognized and are much more frequent as compared to rare homozygotes. Therefore, genotyping data provided exact blood group allele frequency estimates. 0007) ). In general, differences in allele frequencies can be observed for all analyzed blood group SNPs. These differences are more pronounced for some blood groups than for others.
Looking at the very rare alleles (MAF < 0.1%), a comparably high variability of (CV > 0.8) across cantons can be observed which may be linked to the fact, that for these even a small changes of MAF has a higher impact on overall frequency. All of the following predicted antigens, Jo(a-), McC b , Wr a , Hy-, Vel-, Tc c , Di a , are observed in some but not all cantons (table 3) . For Vel+/Vel-we saw a correlation of R 2 < 0.7 between sample size and MAF, which explains the observed frequency differences across the cantons by differences in sample sizes. To some extent, this is also true for KEL11/17 with a Spearman correlation coefficient of 0.6. The highest variability across the more frequent rare blood group antigens (MAF > 1%) is seen for Kp a and Kn b followed by Lu a .
Analysis of Inter-Cantonal Blood Group Variability
The PCoA analyses, both on the relative frequencies of the blood group antigens ( fig. 2 ) and the F ST, were performed to visualize frequency differences in the different cantons to facilitate their investigation (supplementary tables 4 and 5; available at http:// content.karger.com/ProdukteDB/produkte.asp?doi=490714). The F ST is used to determine population differences because of genetic differentiation and is usually applied to SNP data. Figure 2 shows the four outlying cantons TI (headed in Lugano), GE (Geneva), VS (Sion), and AG (Aarau) (for abbreviations of canton names, their areas covered and location of headquarters see table 2). It was performed on 13 blood group antigens with mean MAF of 0.1% across the cohorts, e.g. For the Zurich samples, we had access to the ZIP codes of all donors. With this, we were able to classify them into probands living in extremely elevated (>1,500 m) and extremely low (<300 m) regions of the greater cantonal area of Zurich. For these samples, we tested for differences in antigen frequencies according to the altitude above sea level of the region of living with no significant results (data not shown). Of note, out of the total 24,058 samples analyzed, only 40 belonged to the 'extreme height' set. 
Discussion
This country-wide search for rare blood group antigens was conducted to increase the pool of the Swiss rare blood donors and thus to improve the supply of rare blood units. In total 326 Swiss blood donors with rare or extremely rare blood group antigen constellations were identified. Thanks to this pool of rare blood donors, it will be possible to provide rare donor blood on demand, without the need for frozen stocks of respective erythrocytes. Once, the expected recognition of molecular specificities had been validated, the 'mission' could be accomplished without the need of commercially available typing sera, e.g. diagnostic antibodies, some of them directed against Au b , Di a , Co b , Do a , Js a and SC2 notoriously being unobtainable [11, 12] .
Molecular blood group typing also allowed for correct identification of heterozygotes for all antigens investigated, thereby delivering exact frequency data. Frequencies of certain antigens differed pronouncedly among different regions of Switzerland. Based on Fig. 3 these results, targeted searches for certain rare phenotypes focused on regions with expected higher occurrence of the respective rare antigens are possible in the future. For instance, individuals negative for Vel were to be expected once among 2,025 inhabitants covered by BTS of Aarau, in comparison to one Vel-among 146,689 inhabitants, expected by Hardy-Weinberg proportions, of the Italian part of Switzerland and represented by the BTS headed in Lugano [24] . Of course, it is expected, that the same local antigen frequencies will be observed in the local patients. Thereby, such frequencies have important clinical implications, on one hand with respect to the expected occurrence of the respective antigens among patients and on the other hand, and as an indirect result, with respect to the prevalence of respective antibodies directed against them.
Previous genetic studies on the European population have revealed a substructure within Switzerland [32, 33] . Using a genomewide set of common markers, the existing 'language clusters' (fig. 4) were re-identified within Switzerland. These studies showed (again) that genetic distance varies with geographic distance and that language is an important barrier for reproduction. Geographically, TI (Lugano), and VS (Sion) are located south, whereas GR (Chur) lies within the massive mountain wall of the Swiss Alps ( fig. 1 ). This 'wall' reaches maximal altitudes of up to 4634 m (peak Dufourspitze) above sea level. First inspections with respect to VEL*-01 allele prevalence, seemed to show that it is much rarer south than in the north of the Alps. However, the greater cantonal area of ZH (Zurich) north of the Alps proved this hypothesis statistically wrong, or alternatively, and purely speculative, suggested this region having predominantly been populated from the southern part of the Alps. Additionally, Switzerland also has a very distinct language profile with four spoken languages, French, German, Italian and Rhaeto-Romanic, also known as 'Romansch' (fig. 4) [34] . Of the analyzed cantons, GE, VD, NE, and some parts of JU and VS belong to the French, TI and some parts of GR to the Italian, and some parts mainly located in GR and partially in TI to the RhaetoRomanic speaking regions, whereas all other cantons are in regions where the generally spoken language is German. This language profile may also be reflected in the ethnic and genetic background of the local blood donors investigated. The cantons BS and BL with their capitol of Basel, for instance, are both located close to France but have a German language profile and cluster between the cantons with German and French language profiles. GR with its capitol Chur and TI with its capitol Lugano both share Italian and RhaetoRomanic influences and cluster closest together.
However, frequency data need to be interpreted with caution. The rarer certain alleles are observed and the smaller respective donor panels are, the less reliable the frequency estimates might be calculated. For instance, the only Vel-allele carrier identified in the Italian-speaking part of Switzerland also typed phenotypically Vel-and was homozygous for VEL*-01/ VEL*-01. Thereby this individual represented a highly significant statistical outlier, without any further VEL*01/VEL*-01 heterozygotes among 383 other individuals investigated and donating blood in the area of Lugano. There is a chance that this individual is a retired Swiss citizen and 'refugee' from the cold winter climate of Aarau. Similarly, the only Di(a+b-) individual identified within all 37,235 donors investigated, turned out to be an immigrant from Peru.
Heterozygous SNP carriers may also represent an important resource for further scientific analysis of blood group antigen genetics. In heterozygotes, each mutation affecting the allelic expression would become directly visible on the phenotypic level. Previously, the underlying principle had been used to identify K 0 alleles among apparently KEL*01/KEL*02 heterozygotes, but with a discrepant K+k-phenotype [6] . Accordingly, among the total of 2,518 apparently LU*A/LU*B heterozygotes identified in the course of this study, 500 were reinvestigated by serology. All showed a congruent Lu(a+b+) phenotype, suggesting a low frequency of ill expressed Lutheran alleles within Switzerland (data not shown, manuscript in preparation). In addition, the data set allowed for new observations with respect to allelic Lutheran haplotypes, For example, among the samples investigated, six LU*A homozygous samples were identified which also were proven to be homozygous for LU*19. Sequence analysis proved the existence of this new LU allele, now being recognized by the ISBT as LU*01.19 [4, 16] .
The present study is an example for the magnitude of information delivered by applying high-throughput blood group genotyping. Gathered data provided new scientific insights into blood group genetics, completed allele frequency data for practical use, and delivered newly identified blood donors with rare and very rare antigen constellations, now available for the provision of rare donor blood.
